Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aripiprazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101768113A reveals a novel alumina-based purification method for 7-CBQ, significantly reducing BQB impurity and enhancing supply chain reliability for pharmaceutical manufacturers.
Patent CN103787965A details a novel low-dimer synthesis of Aripiprazole using THF and Tosyl Chloride, offering significant cost reduction and purity advantages for pharmaceutical manufacturers.
Patent CN109180577B introduces a superior Aripiprazole synthesis minimizing dimer impurities. Discover cost-effective manufacturing strategies for reliable API intermediate supply.
Patent CN1576273A details a novel Aripiprazole synthesis route offering improved purity and yield. Discover cost reduction in pharmaceutical manufacturing and supply chain benefits.
Novel condensation route avoids harsh conditions, ensuring high purity and cost reduction in pharmaceutical manufacturing for global supply chains.
Patent CN101323590B details a novel Aripiprazole synthesis using Beckmann rearrangement. This route offers cost reduction in API manufacturing and superior supply chain reliability.
Patent CN101781246A details a high-yield two-step synthesis for Aripiprazole using azeotropic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel CN105859703A patent route for Brexpiprazole using 7-hydroxycoumarin. Reduces impurities, lowers cost, ensures supply chain stability for pharma manufacturing.
Novel patent CN107628999A enables high yield Aripiprazole dodecylate synthesis without column chromatography ensuring supply chain stability and cost efficiency for global buyers.
Patent CN115340494A reveals a novel 3-step route for high-purity aripiprazole. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Novel two-step route eliminates dimer byproducts, achieving >99% purity. Ideal for reliable API intermediate supply chains seeking cost reduction.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Patent CN1634889A details a novel synthesis for Aripiprazole intermediates using low-toxicity solvents and improved efficiency for reliable API supply chains.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.
Advanced anhydrous synthesis of Aripiprazole Lauroxil via paraformaldehyde. Delivers high-purity antipsychotic prodrugs with improved yields and cost reduction in API manufacturing.